Drug combination reaches key threshold for ‘functional cure’ of chronic liver infection that affects more than 250 million ...

Entecavir and tenofovir are the two most potent anti-HBV agents with the best resistance profile in nucleo(s)tide-naive patients with chronic hepatitis B. Tenofovir represents the optimal ...

New oral nucleos(t)ide analogs such as entecavir and tenofovir can effectively suppress hepatitis B virus with minimal risk of drug resistance. Many patients, however, develop virologic relapse ...

However, people with HBeAg-negative hepatitis B are more likely to respond to treatment. For example, one study found that among HIV-negative people treated with tenofovir, around 95% of ...

TENOFOVIR DISOPROXIL VIATRIS is used to treat CHB (an infection with hepatitis B virus [HBV]) in adults and paediatric patients aged 12 years and older and weighing at least 35 kg. TENOFOVIR ...

(Smith) Tenofovir and emtricitabine are active against hepatitis B and are recommended components of antiretroviral therapy for people co-infected with hepatitis B and HIV. A drug-resistant HIV strain ...

If you have a long standing viral infection of your liver (hepatitis B) it may flare up when you stop taking TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200. This can cause serious illness ...